NEW YORK (GenomeWeb News) – The Sarcoma Alliance for Research through Collaboration, or SARC, today announced it has received a five-year, $11.5 million grant from the National Cancer Institute to conduct translational research into sarcoma, a relatively rare cancer than can affect bones and soft connective tissues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.